These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 1819733

  • 1. Platelet-activating factor may mediate dexamethasone-induced gastric damage in the rat.
    Filep J, Hermán F, Braquet P.
    Lipids; 1991 Dec; 26(12):1356-8. PubMed ID: 1819733
    [Abstract] [Full Text] [Related]

  • 2. Dexamethasone-induced gastric mucosal damage in the rat: possible role of platelet-activating factor.
    Filep JG, Hermán F, Földes-Filep E, Schneider F, Braquet P.
    Br J Pharmacol; 1992 Apr; 105(4):912-8. PubMed ID: 1324056
    [Abstract] [Full Text] [Related]

  • 3. Protective effect of the PAF-antagonist BN 52021 on several models of gastro-intestinal mucosal damage in rats.
    Etienne A, Thonier F, Braquet P.
    Int J Tissue React; 1989 Apr; 11(2):59-64. PubMed ID: 2693389
    [Abstract] [Full Text] [Related]

  • 4. Effects of the specific platelet-activating factor antagonists, BN 52021 and BN 52063, on various experimental gastrointestinal ulcerations.
    Braquet P, Etienne A, Mencia-Huerta JM, Clostre F.
    Eur J Pharmacol; 1988 Jun 10; 150(3):269-76. PubMed ID: 3046952
    [Abstract] [Full Text] [Related]

  • 5. Role of leukotrienes and platelet activating factor in acute gastric mucosal lesions in rats.
    Konturek SJ, Brzozowski T, Drozdowicz D, Garlicki J, Beck G.
    Eur J Pharmacol; 1989 May 19; 164(2):285-92. PubMed ID: 2759176
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Release of eicosanoids in rat peritoneal cavity stimulated with platelet-activating factor (PAF). Effect of the PAF-antagonist BN-52021.
    Jancar S, Braquet P, Sirois P.
    Prostaglandins Leukot Essent Fatty Acids; 1989 Jul 19; 37(1):23-4. PubMed ID: 2548218
    [Abstract] [Full Text] [Related]

  • 15. Evidence for platelet-activating factor as a late-phase mediator of chronic pancreatitis in the rat.
    Zhou WG, Chao W, Levine BA, Olson MS.
    Am J Pathol; 1990 Dec 19; 137(6):1501-8. PubMed ID: 1701964
    [Abstract] [Full Text] [Related]

  • 16. Free radicals scavengers attenuate platelet-activating factor (PAF)- and endotoxin-induced intestinal myoelectric disturbances in rats.
    Pons L, Droy-Lefaix MT, Braquet P, Buéno L.
    Free Radic Res Commun; 1991 Dec 19; 12-13 Pt 2():629-32. PubMed ID: 2060836
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Platelet-activating factor antagonists treatment protects against postischemic acute renal failure in rats.
    López-Farré A, Bernabeu F, Gómez-Garre D, Ramon y Cajal S, Braquet P, López-Novoa JM.
    J Pharmacol Exp Ther; 1990 Apr 19; 253(1):328-33. PubMed ID: 2329516
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.